¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È£"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • GnRH agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
  • gonadotrophin
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó, ¼º¼±ÀÚ±ØÈ£¸£¸ó
  • gonadotropic hormone
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó, »ý½Ä¼±ÀÚ±ØÈ£¸£¸ó
  • gonadotropic quotient
    »ý½Ä»ùÀÚ±ØÈ£¸£¸óºñ
  • gonadotropin
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó, ¼º¼±ÀÚ±ØÈ£¸£¸ó
  • gonadotropin-releasing hormone
    »ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó, »ý½Ä¼±ÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó
  • gonadotropin-releasing hormone agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • growth hormone-inhibiting hormone
    ¼ºÀåÈ£¸£¸ó¾ïÁ¦È£¸£¸ó
  • growth hormone-releasing hormone
    ¼ºÀåÈ£¸£¸ó¹æÃâÈ£¸£¸ó
  • hypereosinophilia
    °ú´ÙÈ£»ê±¸Áõ°¡Áõ
  • hypereosinophilic syndrome
    °ú´ÙÈ£»ê±¸ÁõÈıº
  • hyperestrinism
    ¿©¼ºÈ£¸£¸ó°ú´Ù(Áõ), °í¿¡½ºÆ®¸°Áõ
  • hypergonadotropic eunuchoidism
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó°ú´ÙÀ¯»ç°íÀÚÁõ
  • hypergonadotropic hypogonadism
    °í»ý½Ä»ùÀÚ±ØÈ£¸£¸ó»ý½Ä»ùÀúÇÏÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • breathing system
    È£ÈíÀåÄ¡
  • hypoventilation
    È£ÈíÀúÇÏ, ȯ±âÀúÇÏ
  • hypoventilation syndrome
    È£ÈíÀúÇÏÁõÈıº
  • respiratory resistance
    È£ÈíÀúÇ×
  • respiratory mucosa
    È£ÈíÁ¡¸·
  • respiratory arrest
    È£ÈíÁ¤Áö
  • respiratory standstill
    È£ÈíÁ¤Áö
  • respiration regulation
    È£ÈíÁ¶Àý
  • pneumotaxic center
    È£ÈíÁ¶Á¤ÁßÃß
  • breathing bag reservoir
    È£ÈíÁÖ¸Ó´Ï
  • respiratory bag
    È£ÈíÁÖ¸Ó´Ï
  • breath holding attack
    È£ÈíÁßÁö¹ßÀÛ
  • breath holding spell
    È£ÈíÁßÁö¹ßÀÛ, ¼ûÂü±â¹ßÀÛ
  • breath holding test
    È£ÈíÁßÁö½ÃÇè, È£ÈíÁßÁö°Ë»ç
  • respiratory center
    È£ÈíÁßÃß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • district nurse
    (¢¡community) Áö¿ª»çȸ°£È£»ç
  • drug interaction
    ¾à¹°»óÈ£ÀÛ¿ë
  • ear protection device
    ¹æÀ½º¸È£±¸, ±Í¸¶°³
  • exertional dyspnea
    ¿îµ¿È£Èí°ï¶õ
  • expiratory dyspnea
    ³»½¬±â°ï¶õ, È£½ÄÈ£Èí°ï¶õ
  • hormonal disorder
    ³»ºÐºñÀå¾Ö, È£¸£¸óÀå¾Ö
  • idiopathic respiratory distress
    Ư¹ßÈ£Èí°ï¶õ
  • inspiratory dyspnea
    µé¿©½¬±â°ï¶õ, Èí½ÄÈ£Èí°ï¶õ
  • mucosal protective drug
    Á¡¸·º¸È£Á¦
  • nocturnal dyspnea
    ¾ß°£È£Èí°ï¶õ
  • orthostatic dyspnea
    ¼­¼­½¬±âÈ£Èí°ï¶õ, ±â¸³È£Èí°ï¶õ
  • paroxysmal dyspnea
    ¹ßÀÛÈ£Èí°ï¶õ
  • paroxysmal nocturnal dyspnea
    ¹ßÀ۾߰£È£Èí°ï¶õ
  • phase encode direction
    À§»óºÎȣȭ¹æÇâ
  • quadrature signal detection
    ±¸Àû½ÅȣŽÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen-antibody interaction
    Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
  • antihormone
    ¾ÈƼȣ¸£¸ó, Ç×È£¸£¸ó.
  • antimullerian hormone
    Ç× ¹Ä·¯¸®¾È È£¸£¸ó
  • antimullerian hormone
    Ç×¹Á·¯¸®¾È È£¸£¸ó
  • antineutrophil cytoplasmic autoantibody
    Ç×È£Áß±¸ ¼¼Æ÷Áú ÀÚ°¡Ç×ü
  • antiprolactin antibody
    Ç×ÇÁ·Î¶ôƾ Ç×ü,Ç×À¯ÁóºÐºñÈ£¸£¸óÇ×ü
  • ards(adult respiratory disress syndrome)
    ARDS(¼ºÀÎÈ£Èí°ï¶õÁõÈıº)(à÷ìÑû¼ýåÍÝÑññøý¦ÏØ)
  • argininosuccinic aciduria
    ¾Æ¸£±â´Ñ È£¹Ú»ê´¢.
  • arginosuccinic lyase
    ¾Æ¸£±â´ÑÈ£¹Ú»ê¸®¾ÆÁ¦<--Àý´ÜÈ¿¼Ò>
  • arsenic paste
    ¾Æºñ»êÈ£Á¦(ä¬Ý÷ß«ûÕð¥).
  • arsenicophagy
    ºñ¼Ò±âÈ£Áõ(¡­Ðîû¿ñø).
  • artificial breathing =a. respiration
    ÀΰøÈ£Èí(¡­û¼ýå).
  • artificial respiration
    ÀΰøÈ£Èí(ìÑÍïû¼ýå)
  • artificial respiration
    ÀΰøÈ£Èí.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • acidophilic metamyelocyte juvenile acidophilic leukocyte
    È£»ê¼º´Ê°ñ¼ö¼¼Æ÷ ¾î¸°È£»ê¼º¹é
  • acidophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
  • eosinophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
  • acidophilic adenoma
    È£»ê¼º¼±Á¾
  • acidophilic cell
    È£»ê¼º¼¼Æ÷
  • oxyphilic cell
    È£»ê¼º¼¼Æ÷
  • oxyphil
    È£»ê¼ºÀÇ, »êģȭ¼ºÀÇ.
  • acidophilic erythroblast
    È£»ê¼ºÀûÇ÷±¸¸ð¼¼Æ÷
  • acidophilic body
    È£»ê¼ºÃ¼(û¿ß«àõô÷)
  • acidophilic promyelocyte
    È£»ê¼ºÇ²°ñ¼ö¼¼Æ÷
  • acidophile
    È£»ê¼¼±Õ
  • bacterium, acidophilic(-phil)
    È£»ê¼¼±Õ
  • oxyphilic adenoma
    È£»ê¼¼Æ÷¼±Á¾(û¿ß«á¬øààÍðþ)
  • arcwise connection
    È£»ó¿¬°á(¡­È£»ó¿¬°á).
  • pes arcuatus ³ª
    È£»óÁ·(ûÁßÒðë)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • basophilic hyperpituitarism
    È£¿°±â¼º ³úÇϼöü±â´ÉÇ×ÁøÁõ.
  • basophilic hypersensitivity
    È£¿°±â±¸ °ú¹Î¹ÝÀÀ
  • basophilic leukemia
    È£¿°±â¼º ¹éÇ÷º´(?ËÑÌ´ËÓ).
  • basophilic leukemia
    È£¿°±â±¸¼º ¹éÇ÷º´(¡­ÛÜúìÜ»).
  • basophilic leukocyte
    È£¿°±â±¸<¼¼Æ÷>(Ì´Ëç˻˴ËṴ̂).
  • basophilic leukocyte
    È£¿°±â¼º¹éÇ÷±¸
  • basophilic metaleukocyte juvenile basophilic leukocyte
    È£¿°±â¼º´Ê°ñ¼ö¼¼Æ÷ ¾î¸°È£¿°±â
  • basophilic myelocyte
    È£¿°±â¼º °ñ¼ö±¸(?Ë­ËàË´).
  • basophilic myelocyte
    È£¿°±â¼º°ñ¼ö¼¼Æ÷
  • basophilic normoblast
    È£¿°±â¼º Á¤Àû¾Æ±¸(?ËøËøËâË´).
  • basophilic promyelocyte
    È£¿°±â¼ºÇ²°ñ¼ö¼¼Æ÷
  • basophilic stippling
    È£¿°±â¼º ¹ÝÁ¡
  • basophils
    È£¿°±â±¸<¼¼Æ÷>.
  • bell note
    ¹æ¿ï¼Ò¸® È£ÈíÀ½.
  • big brg prolactin
    °Å´ë À¯ÁóºÐºñÈ£¸£¸ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • shield
    "º¸È£ÆÇ(ÜÁûÞ÷ù), Â÷´ÜÆÇ(ó´Ó¨÷ù)"
  • short range interaction
    ´Ü¹üÀ§ »óÈ£ÀÛ¿ë(Ó­ÛôêÌßÓû»íÂéÄ)
  • signal amplification
    ½ÅÈ£ÁõÆø(ãáûÜñòøë)
  • signal codons
    ½ÅÈ£(ãáûÜ)ÄÚµ·
  • signal hypothesis
    ½ÅÈ£¼³(ãáûÜàã)
  • signal peptide
    ½ÅÈ£(ãáûÜ)ÆéŸÀ̵å
  • signal peptidase
    ½ÅÈ£(ãáûÜ)ÆéƼµ¥À̽º
  • signal recognition protein
    ½ÅÈ£ÀÎÁö´Ü¹éÁú(ãáûÜìãò±Ó±ÛÜòõ)
  • signal sequence
    ½ÅÈ£¼­¿­(ãáûÜßíÖª)
  • signal-to-noise ratio
    ½ÅÈ£/ÀâÀ½ºñ(ãáûÜ/íÚëåÝï)
  • sign inversion mechanism
    ½ÅÈ£¹ÝÀü±âÀü(ãáûÜÚãï®Ñ¦ï®)
  • sign mutation
    ½ÅÈ£º¯ÀÌ(ãáûÜܨì¶)
  • somatotropin regulatory hormone
    ¼Ò¸¶Å䯮·ÎÇÉ Á¶Àý(ðàï½)È£¸£¸ó
  • somatotropin releasing hormone
    ¼Ò¸¶Å䯮·ÎÇÉ ¹æÃâ(Û¯õó) È£¸£¸ó
  • specific interaction theory
    ƯÀÌ »óÈ£ÀÛ¿ëÀÌ·Ð(÷åì¶ßÓû»íÂéÄ×âÖå)
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • J68
    Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
    È­Çй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±èÀÇ ÈíÀÔ¿¡ ÀÇÇÑ È£Èí±â º´ÅÂ
  • J68.3
    Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
    È­Çй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ ±âŸ ±Þ¼º ¹× ¾Æ±Þ¼º È£Èí±â º´ÅÂ
  • J68.4
    Chronic respiratory conditions due to chemicals, gases, fumes and vapours
    È­Çй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ ¸¸¼º È£Èí±â º´ÅÂ
  • J68.8
    Other respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
    ±âŸ È­Çй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ È£Èí±â º´ÅÂ
  • J68.9
    Unspecified respiratory condition due to inhalation of chemicals, gases, fumes and vapours
    »ó¼¼ºÒ¸íÀÇ È­Çй°Áú, ±âü, ÈÆÁõ±â ¹× ¹°±è¿¡ ÀÇÇÑ È£Èí±â º´ÅÂ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • expiration
    È£±â, È£½Ä, ³»½°
    ¼ûÀ» ³»½¬´Â µ¿ÀÛ. Æó·ÎºÎÅÍ °ø±â¸¦ ¹èÃâÇÏ´Â °Í.
  • expiratory
    È£±âÀÇ
  • expiratory dyspnea
    È£½Ä¼º È£Èí °ï¶õ
  • expiratory phase
    È£±â
  • expiratory reserve volume
    È£½Ä¼º ¿¹ºñ ¿ëÀû, È£±â ¿¹ºñ·®, ¿¹ºñ È£±â·®
    ¾ÈÁ¤ »óÅÂÀÇ È£½Ä ÈÄ ÃÖ´ë·Î È£ÃâÇÒ ¼ö ÀÖ´Â °ø±â·®À¸·Î¼­, ¾à 1200mlÀÌ´Ù.
  • expiratory vital capacity
    È£½Ä ÆóȰ·®
  • expired
    È£±âÀÇ
  • expired air breathing
    È£±â È£Èí¹ý
  • expired gas
    È£±â
  • expressive or signal output process
    Ç¥Çö¼º, ȤÀº ½ÅÈ£ÀÇ Ãâ·ÂÈ­ °úÁ¤
  • external respiration
    ¿ÜÈ£Èí
    ÆóÀå°ú ´ë±â »çÀÌ¿¡¼­ ÀϾ´Â °¡½º ±³È¯.
  • facial protector
    ¾È¸é º¸È£±â, ¾È¸é ½Å°æ º¸È£±â
  • familial neutropenia
    °¡Á·¼º È£Áß±¸ °¨¼ÒÁõ
  • favoring
    ¼±È£ÇÏ´Â
  • female hormone
    ¿©¼º È£¸£¸ó
    ôÃß µ¿¹° ¾ÏÄÆÀÇ ³­¼Ò¿¡¼­ ºÐºñµÇ¾î ¼º±âÀÇ ¹ßÀ°°ú »ý½Ä±â´É Á¶Àý µî¿¡ ÀÛ¿ëÇÏ´Â ¼º È£¸£¸ó. ³­¼Ò È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. ¿©Æ÷¿¡¼­ ³ª¿À´Â ¿©Æ÷ È£¸£¸ó°ú Ȳü¿¡¼­ ³ª¿À´Â Ȳü È£¸£¸óÀÌ ÀÖ´Ù. ÀÇ¾à ¹æ¸é¿¡¼­ º¸Åë ¿©¼º È£¸£¸óÀ̶ó°í ÇÒ ¶§´Â ¿©Æ÷ È£¸£¸óÀ» ¸»ÇÑ´Ù. ¿©Æ÷ È£¸£¸óÀº ¹ßÁ¤ È£¸£¸óÀ¸·Î ¿©¼º »ý½Ä±âÀÇ ¹ßÀ°À» ÃËÁøÇÏ¿© ¿©¼º´Ù¿òÀ» ÁõÁø½ÃŲ´Ù. Ȳü È£¸£¸óÀº ¹ßÁ¤ È£¸£¸ó¿¡ ±æÇ×ÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¹ßÁ¤À» ¾ïÁ¦ÇÑ´Ù. À̵é È£¸£¸óÁ¦ÀÇ »ç¿ëÀº ÀÎü¿¡ ÀÌ»óÇÑ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ¼ö°¡ ÀÖÀ¸¹Ç·Î ±× »ç¿ëÀº ¹Ýµå½Ã Àü¹® ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó¾ß ÇÑ´Ù. ¹ßÁ¤ È£¸£¸óÀÇ ÀÛ¿ëÀ» °¡Áø ¹°ÁúÀ» ÃÑÄªÇØ¼­ ¿¡½ºÆ®·Î°Õ
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • magniloquent
    È£¾ðÀå´ãÇÏ´Â
  • magniloquent
    È£¾ðÀå´ãÇÏ´Â;°úÀåÇÑ
  • rant
    È£¾ðÇÏ´Ù
  • Hohenstaufed
    È£¿£½´Å¸¿ìÆæ(12-13¼¼±âÀÇ µ¶ÀÏÀÇ ¿Õ°¡)
  • Hohenzollern
    È£¿£ÃÍ·¹¸¥°¡(ÀÇ »ç¶÷)(1871-1918³â µ¶ÀÏÀ» Áö¹èÇÑ ¿Õ°¡)
  • mouthfilling
    È£¿¬ Àå´ãÇÏ´Â
  • halophile
    È£¿°±Õ
  • basophil
    È£¿°±â¼º
  • basophile
    È£¿°±â¼º
  • basophil
    È£¿°±â¼º ¹éÇ÷±¸
  • basophile
    È£¿°±â¼º ¼¼Æ÷(ƯÈ÷ ¹éÇ÷±¸)
  • basophilic
    È£¿°±â¼º ¼¼Æ÷(ƯÈ÷ ¹éÇ÷±¸)ÀÇ
  • halobacteria
    È£¿°¼º ¼¼±Õ
  • drencher
    È£¿ì;Æø¿ì;(¸¶¼Ò¿ëÀÇ)¹°¾à ¸ÔÀÌ´Â ±â±¸
  • bodyguard
    È£À§;È£À§º´
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • quixotism
    µ¿Å°È£Å×ÀûÀÎ ¼º°Ý
  • quixotry
    µ¿Å°È£Å×ÀûÀÎ ¼º°Ý
  • rant
    È£¾ðÇÏ´Ù
  • reciprocal
    ¼­·Î°£ÀÇ; »óÈ£ÀÇ
  • reciprocity
    »óÈ£°ü°è
  • refuge
    º¸È£(ÀÚ); À§¾È¹°; Çdz­(ó)
  • resolute
    ´ÜÈ£ÇÑ; ±»°ÇÇÑ
  • respiration
    È£Èí
  • respirator
    ÀΰøÈ£Èí
  • respiratory
    È£ÈíÀÇ
  • respire
    È£ÈíÇÏ´Ù
  • rifle pit
    »ç°ÝÈ£
  • rye
    È£¹Ð
  • safeguard
    À» º¸È£ÇÏ´Ù
  • salacious
    È£»öÀûÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á